These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 36015182)
1. Residual Microscopic Peritoneal Metastases after Macroscopic Complete Cytoreductive Surgery for Advanced High-Grade Serous Ovarian Carcinoma: A Target for Folate Receptor Targeted Photodynamic Therapy? Moinard M; Augustin J; Carrier M; Da Maïa E; Penel A; Belghiti J; Nikpayam M; Gonthier C; Canlorbe G; Acherar S; Delhem N; Frochot C; Uzan C; Azaïs H Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015182 [TBL] [Abstract][Full Text] [Related]
2. Microscopic Peritoneal Residual Disease after Complete Macroscopic Cytoreductive Surgery for Advanced High Grade Serous Ovarian Cancer. Azaïs H; Vignion-Dewalle AS; Carrier M; Augustin J; Da Maïa E; Penel A; Belghiti J; Nikpayam M; Gonthier C; Ziane L; Mordon S; Collinet P; Canlorbe G; Uzan C J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375564 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study. Azaïs H; Schmitt C; Tardivel M; Kerdraon O; Stallivieri A; Frochot C; Betrouni N; Collinet P; Mordon S Photodiagnosis Photodyn Ther; 2016 Mar; 13():130-138. PubMed ID: 26200606 [TBL] [Abstract][Full Text] [Related]
5. The feasibility of folate receptor alpha- and HER2-targeted intraoperative fluorescence-guided cytoreductive surgery in women with epithelial ovarian cancer: A systematic review. de Jong JM; Hoogendam JP; Braat AJAT; Zweemer RP; Gerestein CG Gynecol Oncol; 2021 Aug; 162(2):517-525. PubMed ID: 34053747 [TBL] [Abstract][Full Text] [Related]
6. Dealing with microscopic peritoneal metastases of epithelial ovarian cancer. A surgical challenge. Azaïs H; Estevez JP; Foucher P; Kerbage Y; Mordon S; Collinet P Surg Oncol; 2017 Mar; 26(1):46-52. PubMed ID: 28317584 [TBL] [Abstract][Full Text] [Related]
7. Fischer 344 Rat: A Preclinical Model for Epithelial Ovarian Cancer Folate-Targeted Therapy. Azaïs H; Queniat G; Bonner C; Kerdraon O; Tardivel M; Jetpisbayeva G; Frochot C; Betrouni N; Collinet P; Mordon S Int J Gynecol Cancer; 2015 Sep; 25(7):1194-200. PubMed ID: 26244757 [TBL] [Abstract][Full Text] [Related]
8. Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience. Deraco M; Sinukumar S; Salcedo-Hernández RA; Rajendra VJ; Baratti D; Guaglio M; Nizri E; Kusamura S Eur J Surg Oncol; 2019 Nov; 45(11):2103-2108. PubMed ID: 31230982 [TBL] [Abstract][Full Text] [Related]
9. [Intraperitoneal photodynamic therapy for peritoneal metastasis of epithelial ovarian cancer. Limits and future prospects]. Azaïs H; Mordon S; Collinet P Gynecol Obstet Fertil Senol; 2017 Apr; 45(4):249-256. PubMed ID: 28373041 [TBL] [Abstract][Full Text] [Related]
13. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer. Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336 [TBL] [Abstract][Full Text] [Related]
14. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center. Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283 [TBL] [Abstract][Full Text] [Related]
15. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer. Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829 [TBL] [Abstract][Full Text] [Related]
16. Is cholecystectomy and removal of the round ligament of the liver a necessary step in cytoreductive surgery and HIPEC, for peritoneal carcinomatosis? Halkia E; Kopanakis N; Valavanis C; Nikolaou G; Zouridis A; Vafias E; Datsis A; Spiliotis J Ann Ital Chir; 2015; 86(4):323-6. PubMed ID: 26344805 [TBL] [Abstract][Full Text] [Related]
17. Patterns of pathological response to neoadjuvant chemotherapy and its clinical implications in patients undergoing interval cytoreductive surgery for advanced serous epithelial ovarian cancer- A study by the Indian Network for Development of Peritoneal Surface Oncology (INDEPSO). Bhatt A; Sinukumar S; Mehta S; Damodaran D; Zaveri S; Kammar P; Mishra S; Parikh L; Ranade R; Penumadu P; Rajan F Eur J Surg Oncol; 2019 Apr; 45(4):666-671. PubMed ID: 30661922 [TBL] [Abstract][Full Text] [Related]
18. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review. Auer RC; Sivajohanathan D; Biagi J; Conner J; Kennedy E; May T Eur J Cancer; 2020 Mar; 127():76-95. PubMed ID: 31986452 [TBL] [Abstract][Full Text] [Related]
19. Cytoreductive surgery under aminolevulinic acid-mediated photodynamic diagnosis plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from ovarian cancer and primary peritoneal carcinoma: results of a phase I trial. Liu Y; Endo Y; Fujita T; Ishibashi H; Nishioka T; Canbay E; Li Y; Ogura S; Yonemura Y Ann Surg Oncol; 2014 Dec; 21(13):4256-62. PubMed ID: 25056850 [TBL] [Abstract][Full Text] [Related]
20. A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer. Marrelli D; Petrioli R; Cassetti D; D'Ignazio A; Marsili S; Mazzei MA; Lazzi S; Roviello F Surg Oncol; 2021 Jun; 37():101523. PubMed ID: 33545658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]